JC Medical Announces First U.S. Treatment With J-Valve TAVR Device
News | Heart Valve Technology | January 07, 2019

January 7, 2019 — JC Medical announced the successful treatment of the first U.S. patient with the company’s...

Endologix Ends Unrestricted Sales and Use of Nellix System
News | Stent Grafts | January 07, 2019

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales...

Artificial Intelligence Advances Threaten Privacy of Health Data
News | Artificial Intelligence | January 04, 2019

January 4, 2019 — Advances in...

The 2018 Most Popular Cardiology Topics - FDA approval of Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), and new pacemaker technologies.

The top two articles on DAIC from 2018 included the FDA approval of Andexxa, the first antidote indicated for patients treated with the anticoagulants rivaroxaban (Xarelto) and apixaban (Eliquis), and an article on new pacemaker technologies. 

Feature | January 04, 2019 | Dave Fornell, Editor

January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website...

National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019

January 3, 2019 — Ohio University and the National Academy of Engineering announced the 2019...

Philips Azurion Clarity IQ angiography system at the University of Colorado being used during a CTO case.
360 Photos | 360 View Photos | January 03, 2019

This is a 360 degree photo during a chronic total occlusion (CTO) procedure at the University of Colorado Hospital...

Videos | Cath Lab | January 03, 2019

This is a walk through inside one of the cardiac hybrid cath labs at the...

Videos | EP Lab | January 03, 2019

This is a quick video tour of one of the dedicated...

Videos | Cath Lab | January 03, 2019

This is the newest cardiac cath lab at the ...

FDA Approves Portola Pharmaceuticals' Prior Approval Supplement for Andexxa Generation 2 Manufacturing Process
News | Antiplatelet and Anticoagulation Therapies | January 02, 2019

January 2, 2019 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval...

Overlay Init